BioNTech

BioNTech
Biotech

BioNTech fades cancer vax in late-stage melanoma setting

BioNTech is not planning further trials of its BNT111 vaccine candidate in a specific late-stage refractory melanoma setting, a spokesperson said.
Zoey Becker Oct 20, 2025 3:01pm
BioNTech

BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC

Sep 8, 2025 11:00am
An arrow incrementally going up stairs before pointing straight up Blue background

BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3

Sep 5, 2025 7:30am
layoffs cuts workforce reduction chairs boxes fired

BioNTech cuts 90 more US jobs as part of pipeline realignment

Aug 5, 2025 1:24pm
parasailing over clouds in Salzburg Austria

Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders

Jul 18, 2025 8:30am
layoffs job cuts fired exit restructuring layoff reduction

BioNTech's chief strategy officer heads for the exit

Jul 17, 2025 10:55am